$5.75
0.050.88%
At close: -
$5.79
0.040.70%
After Hours: 4:03 PM EDT
Comments
Loading...
Aveanna Healthcare Hldgs Analyst Ratings and Price Targets | NASDAQ:AVAH | Benzinga
Aveanna Healthcare Holdings Inc has a consensus price target of $3.72 based on the ratings of 11 analysts. The high is $5.5 issued by Truist Securities on April 11, 2025. The low is $1 issued by Credit Suisse on August 11, 2023. The 3 most-recent analyst ratings were released by UBS, Truist Securities, and UBS on May 9, 2025, April 11, 2025, and March 14, 2025, respectively. With an average price target of $5 between UBS, Truist Securities, and UBS, there's an implied -13.64% downside for Aveanna Healthcare Holdings Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Truist Securities
RBC Capital
Deutsche Bank
Credit Suisse
1calculated from analyst ratings
Analyst Ratings for Aveanna Healthcare Hldgs
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/09/2025 | Buy Now | -13.64% | UBS | A.J. Rice70% | $4.5 → $5 | Maintains | Sell | Get Alert |
| 04/11/2025 | Buy Now | -5.01% | Truist Securities | David Macdonald66% | $6 → $5.5 | Maintains | Hold | Get Alert |
| 03/14/2025 | Buy Now | -22.28% | UBS | A.J. Rice70% | $3.2 → $4.5 | Maintains | Sell | Get Alert |
| 01/06/2025 | Buy Now | -9.33% | Truist Securities | David Macdonald66% | $6 → $5.25 | Maintains | Hold | Get Alert |
| 08/09/2024 | Buy Now | -13.64% | RBC Capital | Ben Hendrix61% | $3 → $5 | Maintains | Sector Perform | Get Alert |
| 08/09/2024 | Buy Now | -13.64% | Deutsche Bank | Pito Chickering68% | $3 → $5 | Maintains | Buy | Get Alert |
| 08/09/2024 | Buy Now | -51.64% | UBS | A.J. Rice70% | $1.7 → $2.8 | Maintains | Sell | Get Alert |
| 03/18/2024 | Buy Now | -48.19% | Deutsche Bank | Pito Chickering68% | $2 → $3 | Maintains | Buy | Get Alert |
| 12/13/2023 | Buy Now | — | JP Morgan | Lisa Gill56% | — | Downgrade | Neutral → Underweight | Get Alert |
| 08/11/2023 | Buy Now | -82.73% | Credit Suisse | A.J. Rice70% | → $1 | Reiterates | Underperform → Underperform | Get Alert |
| 07/13/2023 | Buy Now | -70.64% | Truist Securities | David Macdonald66% | $1.4 → $1.7 | Maintains | Hold | Get Alert |
| 05/15/2023 | Buy Now | -65.46% | RBC Capital | Ben Hendrix61% | → $2 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 05/12/2023 | Buy Now | -82.73% | Credit Suisse | A.J. Rice70% | → $1 | Reiterates | Underperform → Underperform | Get Alert |
| 05/12/2023 | Buy Now | — | Raymond James | John Ransom76% | — | Downgrade | Strong Buy → Market Perform | Get Alert |
| 03/20/2023 | Buy Now | -65.46% | RBC Capital | Ben Hendrix61% | $3 → $2 | Maintains | Sector Perform | Get Alert |
| 03/20/2023 | Buy Now | -48.19% | Raymond James | John Ransom76% | $4 → $3 | Maintains | Strong Buy | Get Alert |
| 03/17/2023 | Buy Now | -75.82% | Truist Securities | David Macdonald66% | $1 → $1.4 | Maintains | Hold | Get Alert |
| 01/27/2023 | Buy Now | -82.73% | Credit Suisse | A.J. Rice70% | $2 → $1 | Downgrade | Neutral → Underperform | Get Alert |
| 11/21/2022 | Buy Now | -48.19% | RBC Capital | Frank Morgan45% | $7 → $3 | Downgrade | Outperform → Sector Perform | Get Alert |
| 11/17/2022 | Buy Now | -65.46% | Credit Suisse | A.J. Rice70% | $5.5 → $2 | Downgrade | Outperform → Neutral | Get Alert |
| 11/16/2022 | Buy Now | -30.92% | Raymond James | John Ransom76% | $6 → $4 | Maintains | Strong Buy | Get Alert |
| 11/11/2022 | Buy Now | -74.09% | Stephens & Co. | Scott Fidel69% | $2.25 → $1.5 | Maintains | Equal-Weight | Get Alert |
| 08/19/2022 | Buy Now | -13.64% | Barclays | Sarah James51% | $7 → $5 | Maintains | Overweight | Get Alert |
| 08/15/2022 | Buy Now | 3.63% | Raymond James | John Ransom76% | $8 → $6 | Maintains | Strong Buy | Get Alert |
| 07/22/2022 | Buy Now | -56.82% | Jefferies | Brian Tanquilut46% | $9 → $2.5 | Downgrade | Buy → Hold | Get Alert |
| 07/05/2022 | Buy Now | — | Truist Securities | David Macdonald66% | — | Downgrade | Buy → Hold | Get Alert |
| 06/21/2022 | Buy Now | -39.55% | Stephens & Co. | Scott Fidel69% | $5.5 → $3.5 | Downgrade | Overweight → Equal-Weight | Get Alert |
FAQ
What is the target price for Aveanna Healthcare Hldgs (AVAH) stock?
The latest price target for Aveanna Healthcare Hldgs (NASDAQ:AVAH) was reported by UBS on May 9, 2025. The analyst firm set a price target for $5.00 expecting AVAH to fall to within 12 months (a possible -13.64% downside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aveanna Healthcare Hldgs (AVAH)?
The latest analyst rating for Aveanna Healthcare Hldgs (NASDAQ:AVAH) was provided by UBS, and Aveanna Healthcare Hldgs maintained their sell rating.
When was the last upgrade for Aveanna Healthcare Hldgs (AVAH)?
There is no last upgrade for Aveanna Healthcare Hldgs
When was the last downgrade for Aveanna Healthcare Hldgs (AVAH)?
The last downgrade for Aveanna Healthcare Holdings Inc happened on December 13, 2023 when JP Morgan changed their price target from N/A to N/A for Aveanna Healthcare Holdings Inc.
When is the next analyst rating going to be posted or updated for Aveanna Healthcare Hldgs (AVAH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aveanna Healthcare Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aveanna Healthcare Hldgs was filed on May 9, 2025 so you should expect the next rating to be made available sometime around May 9, 2026.
Is the Analyst Rating Aveanna Healthcare Hldgs (AVAH) correct?
While ratings are subjective and will change, the latest Aveanna Healthcare Hldgs (AVAH) rating was a maintained with a price target of $4.50 to $5.00. The current price Aveanna Healthcare Hldgs (AVAH) is trading at is $5.79, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
